Skip to main content
Qiagen N.V. logo

Qiagen N.V. — Investor Relations & Filings

Ticker · QIA ISIN · NL0015001WM6 LEI · 54930036WK3GMCN17Z57 F Manufacturing
Open in API
Filings indexed 627 across all filing types
Latest filing 2005-08-15 Interim / Quarterly Rep…
Country NL Netherlands
Listing F QIA

About Qiagen N.V.

https://www.qiagen.com/

Qiagen N.V. is a global provider of "Sample to Insight" solutions, offering technologies that transform biological materials into valuable molecular insights. The company develops and markets sample and assay technologies, automated instrumentation, and bioinformatics software for molecular diagnostics, applied testing, academic research, and pharmaceutical development. Its comprehensive portfolio supports the entire workflow from sample collection and preparation of DNA, RNA, and proteins to analysis and interpretation. Key product areas include sample preparation kits, PCR, digital PCR (dPCR), and next-generation sequencing (NGS) solutions, as well as syndromic testing panels for infectious diseases.

Recent filings

Filing Released Lang Actions
FORM 6-K
Interim / Quarterly Report Classification · 100% confidence The document is a Form 6-K filed by a foreign private issuer, QIAGEN N.V., pursuant to SEC rules. It contains unaudited condensed consolidated financial statements for the quarterly period ended June 30, 2005, including balance sheets, income statements, cash flow statements, notes to financial statements, and management's discussion and analysis (Operating and Financial Review and Prospects). The presence of detailed interim financial data and analysis for a period shorter than a full fiscal year (quarterly period) indicates this is an Interim / Quarterly Report. The document is about 15,000 characters long, which is consistent with a full report rather than a brief announcement. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2005-08-15 English
Regulatory Filings 2005
Regulatory Filings Classification · 95% confidence The document is a letter from the SEC staff to QIAGEN N.V. regarding their Form 20-F filing for the fiscal year ended December 31, 2004. The letter contains detailed comments and requests for additional information and explanations about specific accounting treatments and disclosures in the financial statements. It is a review comment letter, not the actual Form 20-F filing itself. The letter references the annual report filing but does not contain the full financial statements or comprehensive company activity report. It is a regulatory review communication, which fits best under Regulatory Filings (RNS) as it is a compliance and disclosure review letter from the SEC staff.
2005-08-12 English
FORM S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as stock option plans. It includes details about the stock plan, number of shares registered, legal opinions, consents, and undertakings related to the registration of shares under the stock plan. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration. Therefore, it fits best under the category of Regulatory Filings (RNS). The document length and content confirm it is a full registration statement, not a brief announcement or a report publication notice.
2005-08-10 English
FORM 6-K
AGM Information Classification · 95% confidence The document is a Form 6-K filed by QIAGEN N.V., a foreign private issuer, containing detailed materials related to the Annual General Meeting (AGM) of shareholders scheduled for June 14, 2005. It includes the Notice of the AGM, agenda items, proxy statements, attendance forms, and the 2004 Annual Report. The content focuses on the AGM logistics, agenda, and proxy solicitation rather than the full annual report itself. The presence of proxy statements, attendance forms, and detailed AGM agenda indicates this is material shared for the AGM. The document length is substantial (15,000 characters), and it contains the actual AGM materials, not just an announcement of the report. Therefore, the document fits best into the category of AGM Information (AGM-R).
2005-07-22 English
FORM 6-K
Interim / Quarterly Report Classification · 100% confidence The document is a Form 6-K filed by a foreign private issuer, QIAGEN N.V., pursuant to SEC rules. It contains unaudited condensed consolidated financial statements for the quarterly period ended March 31, 2005, including balance sheets, income statements, cash flow statements, notes to financial statements, and management's discussion of financial results and prospects. The presence of detailed financial data and analysis for a quarterly period indicates this is an interim or quarterly report. Form 6-K is commonly used by foreign private issuers to furnish such interim financial information to the SEC. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). The document length (15,000 characters) and content confirm it is the report itself, not just an announcement or certification.
2005-05-12 English
FORM 20-F
Annual Report FY 2004
2005-04-19 English

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.